Recently, there is a protein that has been discovered by scientists. This particular protein may help to protect people against Alzheimer's Disease.

Experiments found the degenative brain condition spreads more rapidly in the brains of mice genetically engineered to lack it.

This particular protein is known as LANDO (LV3-associated endocytosis). This particular protein was found to be less abundant by half in brains with Dementia. The findings, published in Science Advances, may lead to a potential therapy for the condition.

One of the researchers and senior author of this study, Dr. Douglas Green, said that they have learned about this pathway in the context of a brain tumor research. Dr. Green is also an immunologist at St. Jude Children's Research Hospital in Memphis, Tennessee.

They also shown a deficiency in LANDO, combined with aging, can lead to Alzheimer's Disease in a unique mouse model, and there is evidence suggesting this could be the case in humans.

The newly identified pathway could also yield strategies for unleashing the immune response against malignant brain tumors.

Reducing neuroinflammation has been proposed as a potential medication. Researchers used a compound that inhibits the "inflammasome", a protein complex that activates proinflammatory immune reactions. They also said that LANDO suggests a significant role in neuro-inflammatory and neuro-degenerative diseases.

There is also a strong possibility it could be targeted as a therapy against cancer or even infectious diseases that rely on similar processes for survival.